CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 23  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0882
LYS 10.0882
GLU 20.0538
LEU 30.0451
ARG 40.0135
CYS 50.0166
GLN 60.0226
CYS 70.0122
ILE 80.0141
LYS 90.0118
THR 100.0074
TYR 110.0152
SER 120.0106
LYS 130.0160
PRO 140.0099
PHE 150.0107
HIS 160.0102
PRO 170.0041
LYS 180.0049
PHE 190.0111
ILE 200.0009
LYS 210.0121
GLU 220.0110
LEU 230.0104
ARG 240.0119
VAL 250.0125
ILE 260.0112
GLU 270.0179
SER 280.0191
GLY 290.0184
PRO 300.0461
HIS 310.0204
CYS 320.0217
ALA 330.0362
ASN 340.0224
THR 350.0198
GLU 360.0111
ILE 370.0113
ILE 380.0095
VAL 390.0088
LYS 400.0042
LEU 410.0084
SER 420.0245
ASP 430.0322
GLY 440.0137
ARG 450.0243
GLU 460.0161
LEU 470.0156
CYS 480.0103
LEU 490.0113
ASP 500.0074
PRO 510.0094
LYS 520.0116
GLU 530.0063
ASN 540.0128
TRP 550.0069
VAL 560.0098
GLN 570.0109
ARG 580.0096
VAL 590.0076
VAL 600.0080
GLU 610.0072
LYS 620.0051
PHE 630.0050
LEU 640.0053
LYS 650.0061
ARG 660.0074
ALA 670.0147
GLU 680.0322
ASN 690.0477

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.